FindTrial
Sign In

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-003188-23-FI
Enrollment
Unknown
Registered
2012-09-13
Start date
2012-09-28
Completion date
Unknown
Last updated
2015-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 18.0 Level: LLT Classification code 10051798 Term: Postoperative constipation System Organ Class: 100000004863 MedDRA version: 18.0 Level: LLT Classification code 10071128 Term: Opioid induced constipation System Organ Class: 100000004856 MedDRA version: 18.0 Level: LLT Classification code 10054711 Term: Postoperative pain System Organ Class: 100000004863 MedDRA version: 18.0 Level: LLT Classification code 10048862 Term: Cesarean section System Organ Class: 100000004865

Interventions

Trade Name: Oxycontin 10 mg Product Name: Oxycontin Product Code: N02AA05 Pharmaceutical Form: Tablet INN or Proposed INN: Oksikodoni hydrokloridi CAS Number: 124-90-3 Other descriptive name: OXYCODON

Sponsors

Merja Kokki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 90 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Contacts

Public ContactMerja Kokki

Kuopion yliopistollinen sairaala

35817173311

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026